Evidence map›Paper›PMID 39211771›Full record

ArticleFrontiers in cardiovascular medicine2024

Case Report: C-reactive protein apheresis in non-ST-elevation ACS-case series from the C-reactive protein apheresis in Acute Myocardial Infarction Registry.

J Torzewski, S Mattecka, F Esposito, F Heigl, J Fiedler, A Sheriff

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J TorzewskiCardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany.
S MatteckaPentracor GmbH, Hennigsdorf, Germany.
F EspositoIntensive Care and Cardiology, Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany.
F HeiglDepartment of Apheresis, Medical Care Center Kempten-Allgäu, Kempten, Germany.
J FiedlerCardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany.
A SheriffPentracor GmbH, Hennigsdorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C-reactive protein (CRP) apheresis has been introduced in ST-elevation myocardial infarction and cardiogenic shock. Here, we describe a first-in-man application in non-ST-elevation acute coronary syndrome (NSTE-ACS). Seven NSTE-ACS patients with high CRP levels (range 14.2-154 mg/L) were treated with CRP apheresis. Treatment was well-tolerated. Patients were discharged in good clinical condition.

Indexed as

acute coronary syndromeanti-inflammatory therapyC-reactive protein apheresisinflammationnon-ST-elevation ACS

Identifiers

PMID39211771
PMCPMC11357922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.